These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 169377)

  • 61. Antibodies from healthy cats exposed to feline leukemia virus lyse feline lymphoma cells slowly with cat complement.
    Grant CK; DeBoer DJ; Essex M; Worley MB; Higgins J
    J Immunol; 1977 Aug; 119(2):401-6. PubMed ID: 196021
    [No Abstract]   [Full Text] [Related]  

  • 62. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection and evaluation of feline oncornavirus-induced cell surface antigen(s) shed from cells in vitro.
    Wolff LH; Mathes LE; Schaller JP; Hoover EA; Olsen RG
    Cancer Res; 1977 Nov; 37(11):4134-7. PubMed ID: 198129
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Feline immunodeficiency syndrome--a comparison between feline T-lymphotropic lentivirus and feline leukemia virus.
    Yamamoto JK; Pedersen NC; Ho EW; Okuda T; Theilen GH
    Leukemia; 1988 Dec; 2(12 Suppl):204S-215S. PubMed ID: 2848998
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Protection of cats against feline leukemia virus-positive and virus-negative tumors by complement-dependent antibody.
    Grant CK; Harris D; Essex ME; Pickard DK; Hardy WD; de Noronha F
    J Natl Cancer Inst; 1980 Jun; 64(6):1527-33. PubMed ID: 6246303
    [No Abstract]   [Full Text] [Related]  

  • 66. [Infections with feline leukemia virus (FeLV) in postmortem cats].
    Reinacher M
    Tijdschr Diergeneeskd; 1987 Jul; 112(14):848-53. PubMed ID: 3039688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Influence of antibody infusion on pathogenesis of experimental feline leukemia virus infection.
    Haley PJ; Hoover EA; Quackenbush SL; Gasper PW; Macy DW
    J Natl Cancer Inst; 1985 Apr; 74(4):821-7. PubMed ID: 2985857
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Naturally occurring persistent feline oncornavirus infections in the absence of disease.
    Essex M; Hardy WD; Cotter SM; Jakowski RM; Sliski A
    Infect Immun; 1975 Mar; 11(3):470-5. PubMed ID: 163793
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Passive immunity to feline leukemia: evaluation of immunity from dams naturally infected and experimentally vaccinated.
    Hoover EA; Schaller JP; Mathes LE; Olsen RG
    Infect Immun; 1977 Apr; 16(1):54-9. PubMed ID: 194840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased risk for lymphoma and glomerulonephritis in a closed population of cats exposed to feline leukemia virus.
    Francis DP; Essex M; Jakowski RM; Cotter SM; Lerer TJ; Hardy WD
    Am J Epidemiol; 1980 Mar; 111(3):337-46. PubMed ID: 6244730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Infection with feline leukemia virus associated with induction of humoral response to a normal cell protein.
    Chen AP; Essex ME
    Cancer Invest; 1984; 2(2):81-90. PubMed ID: 6329486
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reactivation of latent feline leukaemia virus infection.
    Rojko JL; Hoover EA; Quackenbush SL; Olsen RG
    Nature; 1982 Jul; 298(5872):385-8. PubMed ID: 6283387
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies on antibodies against feline leukaemia virus (FeLV) in cat sera and rabbit anti-FeLV sera: cross reaction and differences.
    Calafat J; Weijer K; Hageman PC; Daams H
    J Gen Virol; 1979 Oct; 45(1):217-22. PubMed ID: 93140
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Horizontal transmission of feline leukemia virus under experimental conditions.
    Hoover EA; Olsen RG; Hardy WD; Schaller JP
    J Natl Cancer Inst; 1977 Feb; 58(2):443-4. PubMed ID: 189052
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation of cell-free feline oncornavirus-associated cell membrane antigen.
    Wolff LH; Olsen RG; Hoover EA; Yohn DS; Schaller JP
    J Natl Cancer Inst; 1977 Mar; 58(3):791-3. PubMed ID: 190418
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody in cats to mammalian RNA tumor virus interspecies antigens.
    Olsen RG; Mathes LE; Yohn DS
    Cancer Res; 1975 Sep; 35(9):2580-5. PubMed ID: 50133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epidemiologic association between virus-negative feline leukemia and the horizontally transmitted feline leukemia virus.
    Francis DP; Essex M; Cotter SM; Gutensohn N; Jakowski R; Hardy WD
    Cancer Lett; 1981 Mar; 12(1-2):37-42. PubMed ID: 6268292
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Natural history studies of the feline RNA tumor virus genoma. I. Detection of group specific antigen and C-type particles.
    Gardner MB; Charman HP; Johnson EY; Rongey RW; Gilden RV; Arnstein P; Huebner RJ
    Prog Immunobiol Stand; 1971; 5():231-6. PubMed ID: 4349825
    [No Abstract]   [Full Text] [Related]  

  • 80. Feline oncornavirus-associated cell membrane antigen. V. Humoral immune response to virus and cell membrane antigens in cats inoculated with Gardner-Arnstein feline sarcoma virus.
    Schaller JP; Essex M; Yohn DS; Olsen RG
    J Natl Cancer Inst; 1975 Dec; 55(6):1373-8. PubMed ID: 1206756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.